About
Technology
Issues
FAQ
Links
Official Page
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.